ID: h-b98ff29728
Hypothesis
Gamma entrainment induces activity-dependent BDNF release to rescue NMJ and dendritic spine integrity
High-frequency gamma oscillations stimulate activity-dependent release of brain-derived neurotrophic factor (BDNF) from excitatory terminals, activating TrkB receptors on postsynaptic neurons to promote spine stabilization and prevent gl.
🧬 BDNF (brain-derived neurotrophic factor); NTRK2 (TrkB); CREBBP/EP300 (CREB)🩺 alzheimers🎯 Composite 77%💱 $0.66▼11.8%proposed
Alzheimer's disease
EvidencePending (0%)📖 0 cit🗣 1 debates✓ 3 support✗ 2 oppose
✓ All Quality Gates Passed
🧪 Overview
High-frequency gamma oscillations stimulate activity-dependent release of brain-derived neurotrophic factor (BDNF) from excitatory terminals, activating TrkB receptors on postsynaptic neurons to promote spine stabilization and prevent glutamate receptor internalization. This has the highest druggability potential given extensive TrkB agonist development programs. Critical barrier: BDNF does not cross the blood-brain barrier; systemic TrkB agonists must achieve high CNS penetration, which has historically been the failure mode.
🧬 Mechanism
🔗 Mechanism from KG for BDNF (brain-derived neurotrophic factor); NTRK2 (TrkB); CREBBP/EP300 (CREB)
Auto-built from this analysis's top knowledge-graph edges.
graph TD
excitation_inhibition_imb["excitation/inhibition imbalance"] -->|associated with| Early_Alzheimer_S_Disease["Early Alzheimer'S Disease"]
PV__interneuron_activatio["PV+ interneuron activation"] -->|associated with| excitation_inhibition_bal["excitation/inhibition balance"]
BDNF["BDNF"] -->|activates| TrkB_receptors["TrkB receptors"]
PV__interneuron_activatio_1["PV+ interneuron activation"] -->|causes| Memory_Improvements["Memory Improvements"]
BDNF_2["BDNF"] -->|regulates| gamma_entrainment_memory_["gamma entrainment memory benefits"]
sess_SRB_2026_04_28_h_bdb["sess_SRB-2026-04-28-h-bdbd2120_task_9aae8fc5"] -->|causal extracted| processed["processed"]
style excitation_inhibition_imb fill:#4fc3f7,stroke:#333,color:#000
style Early_Alzheimer_S_Disease fill:#ef5350,stroke:#333,color:#000
style PV__interneuron_activatio fill:#4fc3f7,stroke:#333,color:#000
style excitation_inhibition_bal fill:#81c784,stroke:#333,color:#000
style BDNF fill:#ce93d8,stroke:#333,color:#000
style TrkB_receptors fill:#4fc3f7,stroke:#333,color:#000
style PV__interneuron_activatio_1 fill:#4fc3f7,stroke:#333,color:#000
style Memory_Improvements fill:#4fc3f7,stroke:#333,color:#000
style BDNF_2 fill:#ce93d8,stroke:#333,color:#000
style gamma_entrainment_memory_ fill:#4fc3f7,stroke:#333,color:#000
style sess_SRB_2026_04_28_h_bdb fill:#4fc3f7,stroke:#333,color:#000
style processed fill:#4fc3f7,stroke:#333,color:#000⚖️ Evidence
⚖️ Evidence Matrix3 supports2 contradicts
Contradicts
BDNF does not cross the BBB; CNS penetration is the primary obstacle for all TrkB agonists
Contradicts
TrkB is widely expressed; systemic side effects (appetite, weight, sensory neuron growth) require characterization
📖 Linked Papers
No linked papers recorded for this hypothesis yet.
🏥 Translation
🧬 3D Protein Structure — BDNF
💉 Clinical Trials
No clinical trials data linked to this hypothesis yet.
No curated ClinVar variants loaded for this hypothesis.
Run scripts/backfill_clinvar_variants.py to fetch P/LP/VUS variants.
No DepMap CRISPR Chronos data found for BDNF (brain-derived neurotrophic factor); NTRK2 (TrkB); CREBBP.
Run python3 scripts/backfill_hypothesis_depmap.py to populate.
🏆 Tournament
🏆 Arenas / Elo
No arena matches recorded yet. Browse Arenas →
📊 Market Indicators
7d Trend
↘
Falling
7d Momentum
▼ 2.1%
Volatility
Medium
0.0387
Events (7d)
3
Price History
▼11.8%💾 Resource Usage
No resource usage or linked notebooks recorded for this hypothesis yet.
🔮 Predictions
🔎 Predictions vs Observations2 predictions · 0 with recorded observations
| Prediction | Predicted | Observed | Status | Conf |
|---|---|---|---|---|
| IF 5xFAD mice receive 40Hz gamma entrainment via optogenetic excitation of medial septum cholinergic neurons (100 pulses, 20ms each, 30 min/day) for 14 consecutive days, THEN hippocampal BDNF protein | ≥40% increase in hippocampal BDNF concentration; restoration of CA1 pyramidal neuron spine density to ≥95% of wild-type levels as measured by Golgi-Cox staining | — no observation — | pending | 0.70 |
| IF 40Hz gamma entrainment (same protocol as prediction 1) is co-administered with the selective TrkB antagonist ANA-12 (10mg/kg, i.p., 30 min pre-stimulation) in 5xFAD mice, THEN the gamma-induced inc | Spine density in the ANA-12 + gamma group statistically indistinguishable from vehicle-treated 5xFAD controls (p>0.05, two-way ANOVA with Tukey post-hoc); AMPAR | — no observation — | pending | 0.65 |
🔮 Falsifiable Predictions (2)
pendingconf 70%
IF 5xFAD mice receive 40Hz gamma entrainment via optogenetic excitation of medial septum cholinergic neurons (100 pulses, 20ms each, 30 min/day) for 14 consecutive days, THEN hippocampal BDNF protein levels will increase by ≥40% (ELISA) and dendritic spine density will recover to wild-type baseline
Predicted outcome: ≥40% increase in hippocampal BDNF concentration; restoration of CA1 pyramidal neuron spine density to ≥95% of wild-type levels as measured by Golgi-Co
Falsification: BDNF levels remain within ±15% of sham-stimulated 5xFAD baseline, or spine density fails to exceed AD baseline by more than 10%, within the 3-week observation window.
pendingconf 65%
IF 40Hz gamma entrainment (same protocol as prediction 1) is co-administered with the selective TrkB antagonist ANA-12 (10mg/kg, i.p., 30 min pre-stimulation) in 5xFAD mice, THEN the gamma-induced increase in BDNF and spine density will be fully abolished, with spine density remaining at AD-elevated
Predicted outcome: Spine density in the ANA-12 + gamma group statistically indistinguishable from vehicle-treated 5xFAD controls (p>0.05, two-way ANOVA with Tukey post-h
Falsification: Spine density in the ANA-12 + gamma group remains ≥80% of gamma-alone values, or AMPAR/NMDAR ratio exceeds 1.0 despite TrkB blockade—indicating BDNF/TrkB is not the exclusive mediator of gamma-induced
▸Metadatasource: v1_phase_c_backfill · origin_type: debate_synthesizer
| source | v1_phase_c_backfill |
| origin_type | debate_synthesizer |
| _schema_version | 1 |
📊 Evidence Profile
Evidence Balance
+0%
Certainty
0%
Debates
0
Incoming
0
Outgoing
0
0 supporting
0 contradicting
0 neutral
Public annotations (0)Annotate on Hypothes.is →
No public annotations yet.